Transient neurologic deficit after acetazolamide challenge for computed tomography perfusion imaging

Journal of Computer Assisted Tomography

Volumn 29, Issue 2, 2005, Pages 278-280

  Choksi, Vaishali ^a,b   Hughes, Marion ^a   Selwa, Linda ^a   Hoeffner, Ellen ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Department of Radiology MRI ^*  (United States)

Author keywords

Acetazolamide complication; Cerebral ischemia; Computed tomography perfusion

Indexed keywords

ACETAZOLAMIDE; ACETAZOLAMIDE COMPLICATION; CEREBRAL HAEMODYNAMICS; CEREBRAL ISCHEMIA; COMPUTED TOMOGRAPHY PERFUSION; OCCLUSIVE DISEASE; PERFUSION IMAGING;

ACETAZOLAMIDE; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CARBONATE DEHYDRATASE INHIBITOR;

ADULT; ANAPHYLACTIC SHOCK; ANOREXIA; ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRONCHOSPASM; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIZZINESS; DRUG HYPERSENSITIVITY; FATIGUE; FEMALE; HEADACHE; HEPATIC ENCEPHALOPATHY; HUMAN; LUNG EDEMA; MALAISE; METABOLIC ACIDOSIS; NAUSEA; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; POLYURIA; PRIORITY JOURNAL; PROVOCATION TEST; SKIN TOXICITY; TASTE DISORDER; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY; VERTIGO;

EID: 15744386158     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000154025.26857.91     Document Type: Article

References (13)

1. Hoeffner EG, Case I, Jain R, et al. Cerebral perfusion CT: technique and clinical applications. Radiology. 2004;231:632-644.
2. Eastwood JD, Alexander MJ, Petrella JR, et al. Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. AJNR Am J Neuroradiol. 2002;23:285-287.
3. Vorstrup S, Burn B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke. 1986;17:1291-1298.
4. Nariai T, Suzuki R, Hirakawa K, et al. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol. 1995;16:563-570.
5. Komiyama M, Nishikawa M, Yasui T, et al. Reversible pontine ischemia caused by acetazolamide challenge. AJNR Am J Neuroradiol. 1997;18:1782-1784.
6. Sullivan HG, Kingsbury TB, Morgan ME, et al. The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg. 1987;67:525-534.
7. Hauge A, Nicolaysen G, Thoresen M. Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand. 1983;117:233-239.
8. Derdeyn CP, Grubb RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251-259.
9. Piepgras A, Schmiedek P, Leinsinger G, et al. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke. 1990;21:1306-1311.
10. Gallerani M, Manzoli N, Fellin R, et al. Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. Am J Emerg Med. 2002;20:371-372.
11. 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of the literature. J Neurosurg Anesthesiol. 2003;15:131-139.
12. Venkatesha SL, Umamaheswara Rao GS. Metabolic acidosis and hyperventilation induced by acetazolamide in patients with central nervous system pathology. Anesthesiology. 2000;93:1546-1548.
13. Maisey DN, Brown RD. Acetazolamide and symptomatic metabolic acidosis in mild renal failure. BMJ. 1981;283:1527-1528.